Published online Apr 28, 2018. doi: 10.3748/wjg.v24.i16.1734
Peer-review started: March 13, 2018
First decision: March 30, 2018
Revised: April 1, 2018
Accepted: April 16, 2018
Article in press: April 16, 2018
Published online: April 28, 2018
Core tip: Diversion colitis is characterized by inﬂammation of the mucosa in the defunctioned segment of the colon after colostomy or ileostomy. The vast majority of diverted patients remain asymptomatic, however diversion colitis occurs in almost all diverted patients. Pharmacologic treatment using short-chain fatty acids, mesalamine, or corticosteroids are reportedly effective for those who are not candidates for surgical reestablishment; however, there are no established assessment criteria for determining the severity of diversion colitis, and no management strategies to date. In this mini-review, we summarize and review various recently-reported diversion disease treatments. We hope this review will be useful for future treatment.